• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19.

作者信息

Mendez Sean R, Frank Rachel C, Stevenson Elizabeth K, Chung Mabel, Silverman Michael G

机构信息

Department of Medicine, Massachusetts General Hospital, Boston, MA.

Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, MA.

出版信息

Chest. 2021 Jul;160(1):89-93. doi: 10.1016/j.chest.2021.01.073. Epub 2021 Feb 3.

DOI:10.1016/j.chest.2021.01.073
PMID:33548220
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7857077/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a3/7857077/50d50d2c8c17/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a3/7857077/50d50d2c8c17/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a3/7857077/50d50d2c8c17/gr1_lrg.jpg

相似文献

1
Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19.二氢吡啶类钙通道阻滞剂与重症新型冠状病毒肺炎的风险
Chest. 2021 Jul;160(1):89-93. doi: 10.1016/j.chest.2021.01.073. Epub 2021 Feb 3.
2
Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.长效和中效二氢吡啶类钙通道阻滞剂治疗高血压的效果：18项前瞻性、随机、阳性对照试验的系统评价和荟萃分析
J Cardiovasc Pharmacol Ther. 2018 Sep;23(5):433-445. doi: 10.1177/1074248418771341. Epub 2018 May 8.
3
Case studies in hypertension. Dihydropyridine/nondihydropyridine calcium channel blocker combination therapy.高血压病例研究。二氢吡啶类/非二氢吡啶类钙通道阻滞剂联合治疗
J Clin Hypertens (Greenwich). 2005 Jan;7(1):50-3. doi: 10.1111/j.1524-6175.2005.04091.x.
4
[Drug information about lercanidipine. A new dihydropyridine calcium antagonist for the treatment of arterial hypertension].
Ugeskr Laeger. 2005 Jan 10;167(2):153-5.
5
[Dihydropyridines are not the only antihypertensives. Calcium blockers in the therapy of elderly hypertensive patients].[二氢吡啶类并非唯一的抗高血压药物。老年高血压患者治疗中的钙阻滞剂]
Fortschr Med Suppl. 1989;71:1-18.
6
[Dihydropyridines for treatment of arterial hypertension].
Pharm Unserer Zeit. 2005;34(5):388-91. doi: 10.1002/pauz.200500137.
7
[24-hour perfect BP-lowering therapy using long-acting dihydropyridine calcium channel blockers].使用长效二氢吡啶类钙通道阻滞剂的24小时完美降压疗法
Nihon Rinsho. 2014 Aug;72(8):1461-5.
8
Calcium channel blockers for people with chronic kidney disease requiring dialysis.用于需要透析的慢性肾病患者的钙通道阻滞剂。
Cochrane Database Syst Rev. 2020 Oct 1;10(10):CD011064. doi: 10.1002/14651858.CD011064.pub2.
9
Calcium channel blocker.钙通道阻滞剂
Clin Ther. 2010 Feb;32(2):396; author reply 397. doi: 10.1016/j.clinthera.2010.02.007.
10
[Antihypertensive therapy. Can a calcium antagonist stop arteriosclerosis?].[抗高血压治疗。钙拮抗剂能阻止动脉硬化吗？]
MMW Fortschr Med. 2001 May 31;143(22):53.

引用本文的文献

1
Impact of the COVID-19 pandemic on initiation of antihypertensive drugs in Sweden: an interrupted time series study.COVID-19 大流行对瑞典开始使用抗高血压药物的影响：一项中断时间序列研究。
BMJ Open. 2024 Oct 16;14(10):e082209. doi: 10.1136/bmjopen-2023-082209.
2
Outcome of COVID-19 infection in patients on antihypertensives: A cross-sectional study.高血压患者感染新型冠状病毒肺炎的结局：一项横断面研究。
World J Crit Care Med. 2024 Sep 9;13(3):96882. doi: 10.5492/wjccm.v13.i3.96882.
3
Association of antihypertensive drugs with COVID-19 outcomes: a drug-target Mendelian randomization study.

本文引用的文献

1
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.羟氯喹治疗 COVID-19 住院患者的观察性研究。
N Engl J Med. 2020 Jun 18;382(25):2411-2418. doi: 10.1056/NEJMoa2012410. Epub 2020 May 7.
2
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.肾素-血管紧张素-醛固酮系统抑制剂与新冠病毒风险。
N Engl J Med. 2020 Jun 18;382(25):2441-2448. doi: 10.1056/NEJMoa2008975. Epub 2020 May 1.
3
Management of COVID-19 Respiratory Distress.新型冠状病毒肺炎呼吸窘迫的管理
抗高血压药物与COVID-19结局的关联：一项药物-靶点孟德尔随机化研究。
Front Pharmacol. 2023 Dec 5;14:1224737. doi: 10.3389/fphar.2023.1224737. eCollection 2023.
4
COVID-19 ORF3a Viroporin-Influenced Common and Unique Cellular Signaling Cascades in Lung, Heart, and the Brain Choroid Plexus Organoids with Additional Enriched MicroRNA Network Analyses for Lung and the Brain Tissues.新型冠状病毒肺炎（COVID-19）开放阅读框3a（ORF3a）病毒孔蛋白对肺、心脏和脑脉络丛类器官中常见和独特的细胞信号级联的影响，并对肺和脑组织进行了额外的富集微小RNA网络分析。
ACS Omega. 2023 Nov 17;8(48):45817-45833. doi: 10.1021/acsomega.3c06485. eCollection 2023 Dec 5.
5
Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms.新冠病毒与帕金森病/阿尔茨海默病之间的关联：相互影响、医疗保健策略和潜在机制。
Transl Neurodegener. 2023 Jan 30;12(1):5. doi: 10.1186/s40035-023-00337-1.
6
Network-Based Data Analysis Reveals Ion Channel-Related Gene Features in COVID-19: A Bioinformatic Approach.基于网络的数据分析揭示 COVID-19 中与离子通道相关的基因特征：一种生物信息学方法。
Biochem Genet. 2023 Apr;61(2):471-505. doi: 10.1007/s10528-022-10280-x. Epub 2022 Sep 14.
7
Effects of nutrients on immunomodulation in patients with severe COVID-19: Current knowledge.营养物质对重症新型冠状病毒肺炎患者免疫调节的影响：当前认知
World J Crit Care Med. 2022 Jul 9;11(4):201-218. doi: 10.5492/wjccm.v11.i4.201.
8
Immune system changes in those with hypertension when infected with SARS-CoV-2.高血压患者感染 SARS-CoV-2 时免疫系统的变化。
Cell Immunol. 2022 Aug;378:104562. doi: 10.1016/j.cellimm.2022.104562. Epub 2022 Jun 9.
9
Perspectives on nano-nutraceuticals to manage pre and post COVID-19 infections.关于纳米营养保健品在管理新冠病毒感染前后情况的观点。
Biotechnol Rep (Amst). 2022 Mar;33:e00712. doi: 10.1016/j.btre.2022.e00712. Epub 2022 Feb 11.
10
Clinical outcomes of hypertensive patients with COVID-19 receiving calcium channel blockers: a systematic review and meta-analysis.COVID-19 合并高血压患者接受钙通道阻滞剂治疗的临床结局：系统评价和荟萃分析。
Hypertens Res. 2022 Feb;45(2):360-363. doi: 10.1038/s41440-021-00786-z. Epub 2021 Nov 9.
JAMA. 2020 Jun 9;323(22):2329-2330. doi: 10.1001/jama.2020.6825.
4
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?高血压和糖尿病患者感染新型冠状病毒肺炎（COVID-19）的风险会增加吗？
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.
5
Fifty Years of Research in ARDS. Gas Exchange in Acute Respiratory Distress Syndrome.ARDS 研究五十年。急性呼吸窘迫综合征的气体交换。
Am J Respir Crit Care Med. 2017 Oct 15;196(8):964-984. doi: 10.1164/rccm.201610-2156SO.
6
Severe, Rapidly Reversible Hypoxemia in the Early Period after Bilateral Lung Transplantation.双侧肺移植术后早期严重、快速可逆性低氧血症
Ann Am Thorac Soc. 2016 Jun;13(6):979-85. doi: 10.1513/AnnalsATS.201602-107CC.
7
Acute respiratory distress syndrome.急性呼吸窘迫综合征
Lancet. 2016 Nov 12;388(10058):2416-2430. doi: 10.1016/S0140-6736(16)00578-X. Epub 2016 Apr 28.
8
Inhibition of hypoxic pulmonary vasoconstriction by nifedipine.硝苯地平对缺氧性肺血管收缩的抑制作用。
N Engl J Med. 1981 Jun 25;304(26):1582-5. doi: 10.1056/NEJM198106253042606.